Understand payer decisions: Proactively address payer evidence requirements in your dossier submission

Anticipating the requirements of payers when you submit your HTA dossier for pricing and reimbursement discussions is vital to your success. Get inside look at the value IQVIA can provide at the disease or asset level during this critical process.

Your free information from Citeline’s Scrip, presented in partnership with IQVIA, demonstrates the power of the IQVIA HTA Accelerator tool, which generates essential data like:

• Number of single drug assessments driven by regulatory approvals
• Systematic shifts between positive, conditional, or negative recommendations impacting reimbursement and price
• Differences in outcomes by country
• And much more